Gulf war syndrome: Narrowing the possibilities

Lancet Neurology

Volumn 2, Issue 5, 2003, Pages 272-273

  Haley, Robert W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORGANOPHOSPHATE PESTICIDE; PYRIDOSTIGMINE; SARIN; ARYLDIALKYLPHOSPHATASE; CHEMICAL WARFARE AGENT; ESTERASE; SOMAN;

DISABILITY; ENVIRONMENTAL EXPOSURE; HUMAN; MILITARY SERVICE; NERVE CELL LESION; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PERSIAN GULF SYNDROME; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SHORT SURVEY; SOLDIER; ARTICLE; CHEMICALLY INDUCED DISORDER; GENETICS; METABOLISM; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ARYLDIALKYLPHOSPHATASE; CHEMICAL WARFARE AGENTS; ESTERASES; HUMANS; MAGNETIC RESONANCE IMAGING; NEURONS; PERIPHERAL NERVOUS SYSTEM DISEASES; PERSIAN GULF SYNDROME; SOMAN;

EID: 0042512300     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(03)00376-4     Document Type: Letter

References (20)

1. Haley R.W., Luk G.D., Petty F. Use of structural equation modeling to test the construct validity of a case definition of Gulf War syndrome: invariance over developmental and validation samples, service branches and publicity. Psychiatry Res. 102:2001;175-200.
2. Veterans Benefits Administration Office of Performance Analysis and Integrity Data and Information Services. May 2002 Gulf War Veterans Information System briefing for National Gulf Wr Resource Center. http://www.ngwrc.org/pdf/ GWVISreportSeptember2002.pdf (accessed April 1, 2003).
3. Thompson J. Statement of Joseph Thompson, Under Secretary for Benefits, Department of Veterans Affairs, before the House Committee on Veterans'Affairs, Subcommittee on Benefits, October 26, 1999. http://veterans.house.gov/hearings/ schedule106/oct99/10-26-99/dva.htm (accessed April 1, 2003).
4. Ismail K., Kent K., Brugha T., et al. The mental health of UK Gulf war veterans: phase 2 of a two phase cohort study. BMJ. 325:2002;576.
5. The Riegle Report. US chemical and biological warfare-related dual use exports to Iraq and their possible impact on health consequences of the Gulf War. Committee on Banking Housing and Urban Affairs with respect to export administration. http://www.gulfweb.org/bigdoc/report/riegle1.html (accessed April 1, 2003).
6. Eddington P.G. Gassed in the Gulf: the inside story of the Pentagon-CIA cover-up of Gulf War syndrome. 1997;Insignia Publishing Company, Washington.
7. Tucker JB. Evidence Iraq used chemical weapons during the 1991 Persian Gulf War. Nonproliferation Review/Spring-Summer 1997. http://cns.miis.edu/pubs/ npr/vol04/43/tucker43.pdf (accessed April 1, 2003).
8. Coalition chemical detections and health of coalition troops in detection area. Office of the Special Assistant for Gulf War Illnesses, US Department of Defense, 1996. http://www.gulflink.osd.mil/czech_french/czfr_refs/ n08en011/coalitn.html (accessed April 1, 2003).
9. Henderson R.F., Barr E.B., Blackwell W.B., et al. Response of rats to low levels of sarin. Toxicol Appl Pharmacol. 184:2002;67-76.
10. Kalra R., Singh S.P., Razani-Boroujerdi S., et al. Subclinical doses of the nerve gas sarin impair T cell responses through the autonomic nervous system. Toxicol Appl Pharmacol. 184:2002;82-87.
11. Matin M.A., Hussain K. Striatal neurochemical changes and motor dysfunction in mipafox-treated animals. Methods Findings Exper Clin Pharmacol. 7:1985;79-81.
12. Davies H.G., Richter R.J., Keifer M., Broomfield C.A., Sowalla J., Furlong C.E. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet. 14:1996;334-336.
13. Haley R.W., Billecke S., La Du B.S. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol. 157:1999;227-233.
14. Mackness B., Durrington P.N., Mackness M.I. Low paraoxonase in Persian Gulf War veterans self-reporting Gulf War syndrome. Biochem Biophys Res Commun. 276:2000;729-732.
15. 1H magnetic resonance spectroscopy. Radiology. 215:2000;807-817.
16. Meyerhoff D.J., Lindgren J., Hardin D., Griffis J.M., Weiner M.W. Reduced N-acetylaspartate in the right basal ganglia of ill Gulf War veterans by magnetic resonance spectroscopy. Proc Intl Soc Mag Reson Med. 9:2001;994.
17. Jamal G.A., Hansen S., Apartopoulos F., Peden A. The "Gulf War syndrome": is there dysfunction in the nervous system? J Neurol Neurosurg Psychiatr. 60:1996;449-451.
18. Sharief M.K., Priddin J., Delamont R.S., et al. Neurophysiologic analysis of neuromuscular symptoms in UK Gulf War veterans: a controlled study. Neurology. 59:2002;1518-1525.
19. Haley R.W., Maddrey A.M., Gershenfeld H.K. Severely reduced functional status in veterans fitting a case definition of Gulf War syndrome. Am J Public Health. 92:2002;46-47.
20. Wolfe G.I. Quantitative sensory testing: basic principles and clinical applications. Dumitru D., Amato A.A., Zwarts M. Electrodiagnostic Medicine. 2003;Hanley & Belfus, Philadelphia.